Organization
UMR 8126, CNRS, Villejuif, France
1 abstract
Abstract
ANTI-GALECTIN-9 ANTIBODY AS A NOVEL TREATMENT OPTION IN RHEUMATOID ARTHRITIS TARGETING PATHOGENIC FIBROBLAST-LIKE SYNOVIOCYTESOrg: Aarhus University, Biomedicine, Aarhus, Denmark, Aarhus University, Clinical Medicine, Aarhus, Denmark, Aarhus University Hospital, Rheumatology, Aarhus, Denmark, UMR 8126, CNRS, Villejuif, France, Universite Paris-Saclay, Gustave Roussy, Villejuif, France,